Skip to main content
Premium Trial:

Request an Annual Quote

Johns Hopkins, Jackson Laboratory Subscribe to Celera Databases

NEW YORK, June 11 - Johns Hopkins University and The Jackson Laboratory, a non-profit mammalian genetics research center, have signed multi-year subscriptions to Celera's databases, the company said Monday.

 

The agreement allows researchers at the two institutions full access to all of Celera's databases through the Celera Discovery system, a web-based interface that includes software tools for searching and analyzing Celera's proprietary databases. Financial details were not disclosed, but in the past Celera has charged academic subscribers between $7,000 and $15,000 a year per scientist using the databases. 

 

The subscriptions add to Celera's list of over 30 current subscribers, who include the University of California system, the Max Planck Society for Advancement of Science, the Karolinska Institute, and American Home Products. 

 

"We are pleased that Johns Hopkins, a world leader in medicine and biomedical research, and Jackson Laboratory, the largest and most renowned mammalian genetic center, have chosen to use Celera's accurate and annotated data, including the mouse genome, as well as our advanced tools and software," Craig Venter, president of Celera, said in a statement.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.